Search

everythinglearnresearchcommunity

for

Search:↓

Cultured skin cells can trigger hair growth and the amount of certain proteins they produce affects their ability to regenerate hair follicles.

Melanocyte progenitor cells are found in human fat tissue and can become mature melanocytes, which may help treat skin issues.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Conditioned medium from keratinocytes can improve hair growth potential in cultured dermal papilla cells.

A one-year-old cat had multiple benign skin tumors similar to those known in humans.

Blocking mTORC1 reduces skin tumor growth in mice.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Skin cells control immune cell placement, helping the skin respond better to challenges.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Certain genes help dermal papillae cells in hair follicles grow and group together.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

The woman has a skin condition involving nodules, scars, and hair loss.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Biglycan helps regulate hair growth and regeneration.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Hair repigmentation can indicate malignancy and should be investigated.

Kaposi's sarcoma lesions might originate from benign tissue changes.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Potential therapeutic targets for scarring hair loss are identified.

Bipotent dermal stem cells and specific macrophages are crucial for hair regrowth and regeneration.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.